Abida Raza
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
-
- Medicinal Plants and Neuroprotection
Papers in
- Hepatology 24
- Hepatitis C virus research 23
- Biomaterials 22
- Nanoparticle-Based Drug Delivery 21
- Co-authors
- Muhammad Ovais (16 shared papers)Zabta Khan Shinwari (9 shared papers)Ali Talha Khalil (8 shared papers)Irshad Ahmad (7 shared papers)Nazar Ul Islam (4 shared papers)Muhammad Ayaz (4 shared papers)Muhammad Ali (4 shared papers)Muhammad Adeeb Khan (4 shared papers)
- Journals
- Nanomedicine (5 papers)International Journal of Infectious Diseases (5 papers)Current Pharmaceutical Biotechnology (5 papers)Applied Microbiology and Biotechnology (3 papers)IET Nanobiotechnology (3 papers)
- Partner nations
- PakistanSaudi ArabiaUnited States
In The Last Decade
Abida Raza
84 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 127
- Biomaterials 505
- Complementary and alternative medicine 226
- Drug Discovery 5
- Hepatology 190
- Pharmaceutical Science 146
Countries citing papers authored by Abida Raza
This map shows the geographic impact of Abida Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abida Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abida Raza more than expected).
Fields of papers citing papers by Abida Raza
This network shows the impact of papers produced by Abida Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abida Raza. The network helps show where Abida Raza may publish in the future.
Co-authors
The 25 scholars most cited alongside Abida Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 311 | |
| 2 | 2020 | 190 | |
| 3 | 2018 | 146 | |
| 4 | 2017 | 133 | |
| 5 | 2018 | 128 | |
| 6 | 2017 | 126 | |
| 7 | 2017 | 125 | |
| 8 | 2018 | 120 | |
| 9 | 2018 | 114 | |
| 10 | 1994 | 103 | |
| 11 | 2016 | 76 | |
| 12 | 2022 | 72 | |
| 13 | 2016 | 67 | |
| 14 | 2017 | 63 | |
| 15 | 2001 | 61 | |
| 16 | 2017 | 52 | |
| 17 | 1990 | 49 | |
| 18 | 2001 | 49 | |
| 19 | 2018 | 48 | |
| 20 | 2002 | 40 |
About Abida Raza
Abida Raza is a scholar working on Hepatology, Biomaterials, Pharmaceutical Science, Epidemiology and Molecular Biology, having authored 89 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (23 papers), Nanoparticle-Based Drug Delivery (21 papers), Nanoparticles: synthesis and applications (13 papers), Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Nanoplatforms for cancer theranostics (9 papers), RNA Interference and Gene Delivery (7 papers) and Moringa oleifera research and applications (4 papers). The work is most often cited by research in Biomaterials (505 citations), Complementary and alternative medicine (226 citations), Drug Discovery (5 citations), Hepatology (190 citations) and Pharmaceutical Science (146 citations). Abida Raza has collaborated with scholars based in Pakistan, Saudi Arabia and United States. Frequent co-authors include Muhammad Ovais, Zabta Khan Shinwari, Ali Talha Khalil, Irshad Ahmad, Nazar Ul Islam, Muhammad Ayaz, Muhammad Ali, Muhammad Adeeb Khan, Muthupandian Saravanan and Sudip Mukherjee. Their work appears in journals such as Nanomedicine, International Journal of Infectious Diseases, Current Pharmaceutical Biotechnology, Applied Microbiology and Biotechnology and IET Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.